HPLC assay of fluconazole and its application to patients with early septic shock

Journal of Liquid Chromatography and Related Technologies

Volumn 28, Issue 4, 2005, Pages 571-580

  Aloudah, Nouf M ^a   Radwan, Mahasen A ^a   Al Omar, Nasser F ^b   Jacobs, Sydney ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Early septic shock; Fluconazole; HPLC; Methods validations; Metoclopramide; Patients; Pharmacokinetics

Indexed keywords

ACETIC ACID; ACETONITRILE; AMINES; AMMONIUM COMPOUNDS; BIOASSAY; DRUG PRODUCTS; PATIENT TREATMENT; PHARMACOKINETICS;

FLUCONAZOLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC); METOCLOPRAMIDE (MCP); RELATIVE STANDARD DEVIATION (RSD); SEPTIC SHOCK;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTIFUNGAL AGENT; FLUCONAZOLE; METOCLOPRAMIDE;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG DETERMINATION; DRUG HALF LIFE; DRUG INFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; REPRODUCIBILITY; SEPTIC SHOCK;

EID: 13844282122     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-200047213     Document Type: Article

References (27)

1. Inagaki, K.; Takagi, J.; Lor, E.; Okamoto, M.P.; Gill, M.A. Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography. Ther. Drug Monit. 1992, 14, 306-311.
2. Montero-Gei, F. Fluconazole: pharmacokinetics and indications. Arch. Med. Res. 1993, 24, 377-385.
3. Slotman, G.J.; Burchard, K.W.; D'Arezzo, A.; Gann, D.S. Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J. Trauma-Injury Infect. Crit. Care 1988, 28, 648-654.
4. Yu, M.; Tomasa, G. Double blind, prospective, randomized trial of the adult respiratory distress syndrome. Crit. Care Med. 1993, 21, 1635-1641.
5. Sinuff, T.; Cook, D.J.; Peterson, J.C.; Fuller, H.D. Development, implementation, and evaluation of a ketoconazole practice guideline for ARDS prophylaxis. J. Crit. Care 1999, 14, 1-6.
6. Lelcuk, S.; Huval, W.V.; Valeri, C.R. Inhibition of ischemia induced thromoxane synthetase in man. J. Traum. 1984, 24, 393-396.
7. Jacobs, S.; Price Evans, D.A.; Tariq, M.; Al Omar, N.F. Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit. Care Med. 2003, 31, 1938-1946.
8. Salartash, K.; Gallucci, J.; Quinn, J.; Catalane, E.; Slotman, G. The cardiopulmonary, eicosanoid, and tissue microanatomic effects of fluconazole during graded bacteremia. Shock 1996, 6, 206-212.
9. Steinhilber, D.; Jaschonek, K.; Knospe, J.; Morof, O.; Roth, H.J. Effects of novel antifungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathway. Arzneimittel-Forschung 1990, 40, 1260-1263.
10. Zervos, E.E.; Fink, G.W.; Norman, J.G.; Robson, M.C.; Rosemurgy, A.S. Fluconazole increases bactericidal activity of neutrophils through non-cytokine-mediated pathway. J. Trauma-Injury Infect Crit. Care 1996, 41, 465-470.
11. Vermuyten, K.; Laurijssens, L.; Vanden-Bossche, H. Azole antifungal a weak inhibitors of inducible nitric oxide synthestase in different mouse and human cells. Mycoses 1997, 40, 119-125.
12. Ripa, S.; Ferrante, L.; Prenna, M. Pharmacokinetics of fluconazole in normal volunteers. Chemotherapy 1993, 36, 6-12.
13. Fischman, A.J.; Alpert, N.M.; Livni, E.; Ray, S.; Sinclair, I.; Callahan, R.J.; Correia, J.A.; Webb, D.; Strauss, H.W.; Rubin, R.H. Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob. Agents Chemother. 1993, 37, 1270-1277.
14. Shiba, K.; Saito, A.; Miyahara, T. Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects. Clin. Ther. 1990, 12, 206-215.
15. Tett, S.; Moore, S.; Ray, J. Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunoefficiency virus (HIV) infection compared with those in a group of males without HIV infection. Antimicrob. Agents Chemother. 1995, 39, 1835-1841.
16. Pittrow, L.; Penk, A. Special pharmacokinetics of fluconazole in septic, obese and burn patients. Mycoses 1999, 42, 87-90.
17. El-Yazigi, A.; Ellis, M.; Ernst, P.; Hussein, R.; Baillie, F.J. Effect of repeated dosing on the pharmacokinetics of oral fluconazole in bone marrow transplant patients. J. Clin. Pharmacol. 1997, 37, 1031-1037.
18. Wood, P.; Tarbi, M. Gas chromatography method for the determination of fluconazole, a noval antifungal agent, in human plasma and urine. J. Chromatogr. 1986, 383, 179-186.
19. Debruyne, D.; Ryckelynck, J.P.; Bigot, M.C.; Moulin, M. Determination of fluconazole in biological fluids by capillary column gas chromatography with a nitrogen detector. J. Pharmaceut. Sci. 1988, 77, 534-535.
20. Troke, P.; Andrews, R.; Brammer, K. Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice. Antimicrob. Agents Chemother. 1985, 28, 815-818.
21. Kobayashi, G.; Travis, S.; Medoff, G. Comparsion of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum. Antimicrob. Agents Chemother. 1986, 29, 660-662.
22. Yamaguchi, H.; Uchida, K.; Kawasaki, K.; Matsunaga, T. In vitro activity of fluconazole, a novel bistriazole antifungal agent. Jpn J. Antibiot. 1989, 42, 1-16.
23. Foulds, G.; Brennan, D.; Wajszczuk, C. Fluconazole penetration into cerebrospinal fluid in human. J. Clin. Pharmacol. 1988, 28, 363-366.
24. Hosotsubo, K.K.; Hosotsubo, H.; Nishijima, M.K.; Okada, T.; Taenaka, N.; Yoshiya, I. Rapid determination of serum levels of a new antifungal agent, fluconazole, by high-performance liquid chromatography. J. Chromatogr. A 1990, 529, 223-228.
25. Carrico, C.J.; Meakins, J.L.; Marshall, J.C. Multiple organ failure syndrome. Arch. Surgery 1986, 121, 196-208.
26. Knaus, W.A.; Draper, E.A.; Wagner, D.P.; Zimmerman, J.E. Prognosis in acute organ-system failure. Ann. Surgery 1985, 202, 685-693.
27. Zimmerman, J.E.; Knaus, W.A.; Wagner, D.P.; Sun, X.; Hakim, R.B.; Nystrom, P.O. A comparison of risks and outcomes for patients with organ system failure: 1982-1990. Crit. Care Med. 1996, 24, 1633-1641.